Asia Pacific Immunodiagnostics Market
The Asia Pacific Immunodiagnostics Market size was valued at US$ 2,409.90 Mn in 2023 and is projected to reach US$ 4,252.35 Mn by 2030, growing at a CAGR of 8.5% during 2023 - 2030.
Report Coverage
- Product: Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays
- Clinical Indication: Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics
- End User: Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes
US$ 2,409.90 Mn
Market size in 2023
US$ 4,252.35 Mn
Market Size by 2030
8.5%
CAGR, 2023 - 2030
2024-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Immunodiagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Immunodiagnostics Market Regional Analysis
6.2 Asia Pacific Immunodiagnostics Market Revenue 2021-2030 (US$ Million)
6.3 Asia Pacific Immunodiagnostics Market Forecast Analysis
7. Asia Pacific Immunodiagnostics Market Analysis – by Product
7.1 Enzyme-Linked Immunosorbent Assays
- 7.1.1 Overview
- 7.1.2 Enzyme-Linked Immunosorbent Assays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
7.2 Chemiluminescence Immunoassays
- 7.2.1 Overview
- 7.2.2 Chemiluminescence Immunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
7.3 Radioimmunoassays
- 7.3.1 Overview
- 7.3.2 Radioimmunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8. Asia Pacific Immunodiagnostics Market Analysis – by Clinical Indication
8.1 Infectious Diseases
- 8.1.1 Overview
- 8.1.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.2 Hepatitis+HIV
- 8.2.1 Overview
- 8.2.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.3 Endocrinology
- 8.3.1 Overview
- 8.3.2 Endocrinology: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.4 Gastrointestinal
- 8.4.1 Overview
- 8.4.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.5 Metabolics
- 8.5.1 Overview
- 8.5.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9. Asia Pacific Immunodiagnostics Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.4 Academic & Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic & Research Institutes: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
10. Asia Pacific Immunodiagnostics Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific- 10.2.1 Asia Pacific Immunodiagnostics Market Breakdown, by Key Country, 2024 and 2030 (%)
- 10.2.1.1 Asia Pacific Immunodiagnostics Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 China: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Immunodiagnostics Market Breakdown, by Product
- 10.2.1.1.2 China: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.1.3 China: Asia Pacific Immunodiagnostics Market Breakdown, by End User
- 10.2.1.2 India: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Immunodiagnostics Market Breakdown, by Product
- 10.2.1.2.2 India: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.2.3 India: Asia Pacific Immunodiagnostics Market Breakdown, by End User
- 10.2.1.3 Japan: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Product
- 10.2.1.3.2 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.3.3 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by End User
- 10.2.1.4 Australia: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Product
- 10.2.1.4.2 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.4.3 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by End User
- 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Product
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 bioMerieux SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Danaher Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 DiaSorin SpA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 PerkinElmer Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Siemens Healthcare GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Svar Life Science AB
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
